Phibro Animal Health Corporation
$ 55.16
0.86%
24 Apr - close price
- Market Cap 2,235,895,000 USD
- Current Price $ 55.16
- High / Low $ 55.68 / 53.83
- Stock P/E 24.41
- Book Value 8.20
- EPS 2.26
- Next Earning Report 2026-05-06
- Dividend Per Share $0.48
- Dividend Yield 0.88 %
- Next Dividend Date -
- ROA 0.08 %
- ROE 0.32 %
- 52 Week High 60.08
- 52 Week Low 17.78
About
Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.
Analyst Target Price
$51.20
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-04 | 2025-11-05 | 2025-08-27 | 2025-05-06 | 2025-02-05 | 2024-11-06 | 2024-08-28 | 2024-05-08 | 2024-02-07 | 2023-11-08 | 2023-08-30 | 2023-05-03 |
| Reported EPS | 0.87 | 0.73 | 0.57 | 0.63 | 0.54 | 0.35 | 0.41 | 0.31 | 0.33 | 0.14 | 0.38 | 0.29 |
| Estimated EPS | 0.68 | 0.6 | 0.52 | 0.52 | 0.453 | 0.25 | 0.33 | 0.29 | 0.28 | 0.23 | 0.38 | 0.34 |
| Surprise | 0.19 | 0.13 | 0.05 | 0.11 | 0.087 | 0.1 | 0.08 | 0.02 | 0.05 | -0.09 | 0 | -0.05 |
| Surprise Percentage | 27.9412% | 21.6667% | 9.6154% | 21.1538% | 19.2053% | 40% | 24.2424% | 6.8966% | 17.8571% | -39.1304% | 0% | -14.7059% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.72 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-25 | 2025-12-17 | 2025-09-24 | 2025-06-25 | 2025-03-26 | 2024-12-18 | 2024-09-25 | 2024-06-26 | 2024-03-27 | 2023-12-20 |
| Amount | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PAHC
2026-04-24 01:09:34
BFI Co., LLC and Jack C. Bendheim have filed an Amendment No. 24 to Schedule 13D, reporting their updated ownership of Phibro Animal Health Corporation's Class A Common Stock. They beneficially own 19,591,914 shares, equating to 48.3% of the Class A Common Stock on an as-converted basis, which includes 95,880 Class A shares and 19,496,034 Class B shares. The filing also notes market disposals of Class A shares within the past 60 days.
2026-04-24 00:09:34
Phibro Animal Health Corp. CEO Jack Bendheim, through BFI Co., LLC, sold 21,120 shares of Class A Common Stock for approximately $1.16 million between April 21 and April 23, 2026, pursuant to a Rule 10b5-1 trading plan. These sales occurred after a 222% surge in PAHC shares over the past year, with InvestingPro analysis suggesting the stock is overvalued. Despite these insider sales, the company recently reported strong fiscal Q2 2026 results, surpassing analyst expectations for both EPS and revenue.
2026-04-23 23:09:34
BFI Co., LLC, an entity associated with Phibro Animal Health's President and CEO Jack Bendheim, sold 21,120 Class A Common Stock shares in open-market transactions. The sales, executed under a Rule 10b5-1 trading plan, occurred at weighted average prices between $54 and $56 per share. Following these transactions, BFI Co., LLC holds 95,880 Class A shares, and Jack Bendheim directly holds 16,840 Class A shares.
2026-04-17 10:09:56
A director and a ten percent owner of Phibro Animal Health (PAHC) sold over $1.2 million worth of shares between April 14 and April 16, 2026. This comes after the stock achieved a 216% gain over the past year, trading near its 52-week high, although InvestingPro analysis suggests it may be overvalued. The company recently reported strong fiscal Q2 2026 results, surpassing analyst expectations for both earnings and revenue.
2026-04-17 08:39:35
Jack Bendheim, a director and ten percent owner of Phibro Animal Health Corp (NYSE:PAHC) through BFI Co., LLC, sold shares totaling over $1.2 million between April 14 and April 16, 2026. The sales occurred while the stock was trading near its 52-week high after a significant 216% gain in the past year, with InvestingPro analysis suggesting the stock may be overvalued. Concurrently, Phibro Animal Health reported strong fiscal Q2 2026 results, surpassing analyst expectations for both EPS and revenue.
2026-04-17 00:10:09
Phibro Animal Health Corp's CEO-linked entity, BFI Co., LLC, converted 100,000 shares of Class B Common Stock to Class A and subsequently sold 21,120 Class A shares between April 14 and April 16. These open-market transactions, executed under a Rule 10b5-1 trading plan adopted in December 2025, involved shares sold at weighted average prices ranging from approximately $53.80 to $59.83. Following these sales, BFI Co., LLC indirectly holds 117,000 Class A shares, and CEO Jack Bendheim directly holds an additional 16,840 Class A shares.
